Cytosorbents Corp - The Bradford Era

Press Releases

CytoSorbents Provides Regulatory Update for DrugSorb-ATR

Cytosorbents Corp

May 1, 2025

PRINCETON,N.J. , May 1, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening co...

Press Releases

CytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights

Cytosorbents Corp

April 29, 2025

PRINCETON, N.J. , April 29, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in ...

Press Releases

CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America

Cytosorbents Corp

April 14, 2025

PRINCETON, N.J. , April 14, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in ...

Press Releases

CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants

Cytosorbents Corp

April 4, 2025

PRINCETON, N.J. , April 4, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in t...

Press Releases

CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

Cytosorbents Corp

April 1, 2025

PRINCETON,N.J. , March 31, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in t...

Press Releases

CytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual Audit

Cytosorbents Corp

March 21, 2025

The Company reaffirms previously provided preliminary financial results for the quarter and full year ended December 31, 2024 , and continues to expec...